Angiotensin-converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice

Circulation

Volumn 103, Issue 25, 2001, Pages 3123-3128

  Zaman, A K M Tarikuz ^d   Fujii, Satoshi ^d   Sawa, Hirotumi ^a   Goto, Daisuke ^d   Ishimori, Naoki ^d   Watano, Keiko ^d   Kaneko, Takeaki ^d   Furumoto, Tomoo ^d   Sugawara, Taeko ^d   Sakuma, Ichiro ^d   Kitabatake, Akira ^d   Sobel, Burton E ^b,c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c University of Vermont Colchester Research Facility   (United States)

^d NONE

Author keywords

Coronary disease; Diabetes mellitus; Fibrinolysis; Insulin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPLASTIN;

ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME INHIBITION; FIBRINOLYSIS; HEART MUSCLE FIBROSIS; HEART WEIGHT; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN RESISTANCE; LEAN BODY WEIGHT; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY;

EID: 20244388950     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.25.3123     Document Type: Article

References (37)

1. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
2. Insulin resistance in microvascular angina
3. Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus
4. Inappropriate microvascular constriction produced transient ST-segment elevation in patients with syndrome X
5. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients
6. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria
7. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
8. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysis
9. Increased plasminogen activator inhibitor-1 and vasculopathy: A reconcilable paradox
10. The fat mouse: A powerful genetic model to study elevated plasminogen activator inhibitor 1 in obesity/NIDDM
11. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells
12. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction
13. Early induction of transforming growth factor-β via angiotensin II type I receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats
14. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy
15. Tissue factor expression on macrophages in coronary plaques in patients with unstable angina
16. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: A potential factor predisposing to thrombosis and its persistence
17. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator
18. Ca1DAG-GEFIII activation of Ras, R-Ras, and Rap1
19. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome
20. Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor-type 1 (PAI-1) gene by proinsulin and insulin in vivo
21. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm
22. Induction of plasminogen activator inhibitor type 1 and type 1 collagen expression in rat cardiac microvascular endothelial cells by interleukin-1 and its dependence on oxygen-centered free radicals
23. Tumor necrosis factor regulates type-1 plasminogen activator inhibitor expression in mouse adipose cells
24. Cutaneous wound healing
25. Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men
26. Pancreatic islet blood flow in normal and obese-hyperglycemic (ob/ob) mice
27. Effect of diabetes mellitus on formation of coronary collateral vessels
28. Collateral circulation and diabetes
29. Capillary surface area is reduced and tissue thickness from capillaries to myocytes is increased in the left ventricle of streptozotocin-diabetic rats
30. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels
31. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells
32. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV
33. Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-β synthesis via transcriptional and posttranscriptional mechanisms
34. Angiotensin II increases plas-minogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells
35. Tissue factor gene expression in the adipose tissue of obese mice
36. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis
37. Effects of an angiotensin-converting-enzyme inhibitor on cardiovascular events in high-risk patients